Association of remnant cholesterol with hypertension, type 2 diabetes, and their coexistence: the mediating role of inflammation-related indicators.

"Declarations Ethics approval and consent to participateAll laboratory tests in this study were reviewed by the Ethics Review Board of the National Center for Health Statistics of the Centers for Disease Control and Prevention. All patients signed an informed consent form, and following the principles of the Declaration of Helsinki, the study did not require ethical review by Fujian Medical University. The specific ethical review numbers are as follows: NHANES 2005–2010: Protocol #2005–06; NHANES 2011–2016: Protocol #2011–17; NHANES 2017–2018: Continuation of Protocol #2011–17 (effective through October 26, 2017); Protocol #2018–01 (effective beginning October 26, 2017). Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This research is supported by the High-level Talents research Start-up Project of Fujian Medical University (No. XRCZX2018001), and Joint Funds for the Innovation of Science and Technology of Fujian Province (No. 2021Y9015)."